Alvaro Whittembury,
Gladys Ramirez,
Herminio Hernández,
Alba Maria Ropero,
Steve Waterman,
María Ticona,
Margo Brinton,
Jorge Uchuya,
Mark Gershman, Washington Toledo,
Erin Staples,
Clarense Campos,
Mario Martínez,
Gwong-Jen J Chang,
Cesar Cabezas,
Robert Lanciotti,
Sherif Zaki,
Joel M Montgomery,
Thomas Monath,
Edward Hayes
[show abstract]
[hide abstract]
ABSTRACT: Five suspected cases of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) clustered in space and time following a vaccination campaign in Ica, Peru in 2007. All five people received the same lot of 17DD live attenuated yellow fever vaccine before their illness; four of the five died of confirmed YEL-AVD. The surviving case was classified as probable YEL-AVD. Intensive investigation yielded no abnormalities of the implicated vaccine lot and no common risk factors. This is the first described space-time cluster of yellow fever viscerotropic disease involving more than two cases. Mass yellow fever vaccination should be avoided in areas that present extremely low risk of yellow fever.
Vaccine 09/2009; 27(43):5974-81. · 3.77 Impact Factor
